286 related articles for article (PubMed ID: 16424790)
21. Cardiovascular effects of captopril and enalapril in obese Zucker rats.
Duarte J; Martinez A; Bermejo A; Vera B; Gámez MJ; Cabo P; Zarzuelo A
Eur J Pharmacol; 1999 Jan; 365(2-3):225-32. PubMed ID: 9988106
[TBL] [Abstract][Full Text] [Related]
22. Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril.
Pawlak R; Chabielska E; Matys T; Kucharewicz I; Rółkowski R; Buczko W
J Cardiovasc Pharmacol; 2000 Oct; 36(4):503-9. PubMed ID: 11026653
[TBL] [Abstract][Full Text] [Related]
23. [Protective effects of extract of Ginkgo biloba on vascular endothelial dysfunction induced by AGEs-BSA in vivo].
Li XX; Chen SX; Ye QS; Yu LP; Cao W
Zhong Yao Cai; 2007 Sep; 30(9):1109-13. PubMed ID: 18236757
[TBL] [Abstract][Full Text] [Related]
24. Vascular and renal effects of vasopeptidase inhibition and angiotensin-converting enzyme blockade in spontaneously diabetic Goto-Kakizaki rats.
Cheng ZJ; Grönholm T; Louhelainen M; Finckenberg P; Merasto S; Tikkanen I; Mervaala E
J Hypertens; 2005 Sep; 23(9):1757-70. PubMed ID: 16093923
[TBL] [Abstract][Full Text] [Related]
25. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
[TBL] [Abstract][Full Text] [Related]
26. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
de Nigris F; D'Armiento FP; Somma P; Casini A; Andreini I; Sarlo F; Mansueto G; De Rosa G; Bonaduce D; Condorelli M; Napoli C
Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122
[TBL] [Abstract][Full Text] [Related]
27. Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis.
Lieberman J; Zakria F
Sarcoidosis; 1989 Sep; 6(2):118-23. PubMed ID: 2557660
[TBL] [Abstract][Full Text] [Related]
28. Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.
Seth MK; Hussain ME; Pasha S; Fahim M
Drug Des Devel Ther; 2016; 10():1533-42. PubMed ID: 27143859
[TBL] [Abstract][Full Text] [Related]
29. Comparison of acute cardiovascular effects of cadmium and captopril in relation to oxidant and angiotensin converting enzyme activity in rats.
Puri VN; Saha S
Drug Chem Toxicol; 2003 Aug; 26(3):213-8. PubMed ID: 12953661
[TBL] [Abstract][Full Text] [Related]
30. Propofol increases vascular relaxation in aging rats chronically treated with the angiotensin-converting enzyme inhibitor captopril.
Gragasin FS; Bourque SL; Davidge ST
Anesth Analg; 2013 Apr; 116(4):775-83. PubMed ID: 23429803
[TBL] [Abstract][Full Text] [Related]
31. [Protective effects of metformin on low-density lipoprotein-induced endothelial dysfunction in rats].
Xie W; Zhang SD; Ou XP; Yang TL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):890-3. PubMed ID: 19460701
[TBL] [Abstract][Full Text] [Related]
32. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
Pi XJ; Chen X
J Mol Cell Cardiol; 1989 Dec; 21(12):1261-71. PubMed ID: 2698963
[TBL] [Abstract][Full Text] [Related]
33. Effect of captopril and enalapril on endothelial function in hypertensive patients.
Creager MA; Roddy MA
Hypertension; 1994 Oct; 24(4):499-505. PubMed ID: 8088918
[TBL] [Abstract][Full Text] [Related]
34. Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.
Salvemini D; Pistelli A; Mollace V
Br J Pharmacol; 1993 Jun; 109(2):430-6. PubMed ID: 8358544
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II receptor antagonist improves age-related endothelial dysfunction.
Kansui Y; Fujii K; Goto K; Abe I; Iida M
J Hypertens; 2002 Mar; 20(3):439-46. PubMed ID: 11875311
[TBL] [Abstract][Full Text] [Related]
36. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
Anning PB; Grocott-Mason RM; Lewis MJ
Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Zhu BQ; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Grossman W; Karliner JS; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):31-7. PubMed ID: 12692751
[TBL] [Abstract][Full Text] [Related]
39. KATP channel opening does not contribute significantly to the vasodilatory effect of SH-group-containing ACE inhibitors.
Köppel H; Holzmann S; Klein W; Horn E; Horn S; Gasser R
Heart Vessels; 1996; 11(4):192-6. PubMed ID: 9119808
[TBL] [Abstract][Full Text] [Related]
40. Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats.
Abd El-Aziz MA; Othman AI; Amer M; El-Missiry MA
J Appl Toxicol; 2001; 21(6):469-73. PubMed ID: 11746193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
